Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Drug Metab Pers Ther ; 37(2): 177-190, 2021 12 09.
Article in English | MEDLINE | ID: mdl-34881837

ABSTRACT

OBJECTIVES: GABA and glutamate neurotransmission play critical roles in both the neurobiology of depression and cognition; and Virgin coconut oil (VCO) is reported to support brain health. The present study investigated the effect of VCO on depression-associated cognitive deficits in mice. METHODS: Thirty male mice divided into five groups were either exposed to chronic unpredicted mild stress (CUMS) protocol for 28 days or pre-treated with 3 mL/kg b. wt. of VCO for 21 days or post-treated with 3 mL/kg b. wt. of VCO for 21 days following 28 days of CUMS exposure. Mice were subjected to behavioural assessments for depressive-like behaviours and short-term memory, and thereafter euthanised. Hippocampal tissue was dissected from the harvested whole brain for biochemical and immunohistochemical evaluations. RESULTS: Our results showed that CUMS exposure produced depressive-like behaviours, cognitive deficits and altered hippocampal redox balance. However, treatment with VCO abrogated depression-associated cognitive impairment, and enhanced hippocampal antioxidant concentration. Furthermore, immunohistochemical evaluation revealed significant improvement in GABAA and mGluR1a immunoreactivity following treatment with VCO in the depressed mice. CONCLUSIONS: Therefore, findings from this study support the dietary application of VCO to enhance neural resilience in patients with depression and related disorders.


Subject(s)
Antioxidants , Cognitive Dysfunction , Animals , Antioxidants/pharmacology , Coconut Oil , Cognition , Cognitive Dysfunction/drug therapy , Depression/drug therapy , Hippocampus , Humans , Male , Mice , gamma-Aminobutyric Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...